Heron Therapeutics (HRTX) P/FCF US GAAP (year values)

2019 2020 2021 2022 2023   LTM ? CAGR 5 years ?
P/FCF -14.6 -10.0 -4.36 -1.83 -3.89   -10.7  
Changes by years, y/y, % +54% -31% -57% -58% +113%     -16.3%

Heron Therapeutics. P/FCF

Heron Therapeutics. P/FCF, changes, %

Heron Therapeutics (HRTX) P/FCF US GAAP (quarter values)

2023Q3 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
P/FCF -1.49 -4.23 -9.36 -23.7 -31.6   -10.7
Changes by years, y/y, % -51% +111% +570% +2 075% +2 029%    
Changes by quarters, q/q, % +37% +185% +121% +153% +34%    

Heron Therapeutics. P/FCF

Heron Therapeutics. P/FCF, changes, y/y, %

Heron Therapeutics. P/FCF, changes, q/q, %